LEADING THE CANNABIS REVOLUTION
One of the Strongest Enterprise Investment Scheme Offers You’ll See in 2018
Grow BioTech are a cannabis biotech company with a uniquely global and nimble approach to cannabis science. This means constantly assessing the global-cannabis commercial and scientific landscape and only deploying their research capabilities to address the most exciting opportunities with the greatest scientific, medical and commercial potential.
Grow Biotech P.L.C allows you to access a unique market which is completely new to the UK. The market dynamics appear extremely favourable and the target return is attractive. Grow Biotech is focused on creating game-changing Intellectual Property in the fastest growing industry in the world, Medical Cannabis.
GrowBiotech is Enterprise Investment Scheme (EIS) Eligible.
EIS is a series of UK income and capital gains tax reliefs. The tax relief is intended to offer some compensation for the high risk associated with investing in companies not listed on the stock exchange.
Why Invest in Medical Cannabis?
- Widely thought to be the fastest growing industry in the world
- Legal cannabis forecast to grow from a $20bn global industry to $100bn by 2020
- The European Legal Cannabis Market alone is estimated to be a €56 billion opportunity
- The list of potential uses and medical treatments is very broad but the scientific work still needs to be done
- Big Pharma are largely staying out of the legal cannabis which creates a huge opportunity for cannabis specific biotech companies
Why Invest in Grow BioTech?
- Aiming to Develop one of the World’s Most Valuable portfolios of Cannabis-Intellectual Property Assets by 2022
- Huge Network Within the Cannabis, Biotech and Medical Communities
- Approved Under the Enterprise Investment Scheme (EIS)
- Fast Evolving Business Sector
- Projected High Returns
- Diversification of Risk
How useful was this post?
Click on a star to rate it!